Re: Real world statistics on how her2+ early brst cancer patients are faring in herce
They may need to look at longer term OS. I have been told HR+ tumors can recur after many years, while triple negative disease seems to recur sooner, but if it doesn't in the first 5 years after diagnosis, chances are that it won't ever recur.
Does anyone have info on that? Have I heard that right?
Jacqueline
__________________
Diagnosed age 44, January 2004, 0.7 cm IDC & DCIS. Stage 1, grade 3, ER/PR pos. HER2 pos. clear margins, no nodes. SNB. 35 rads. On Zoladex and Armidex since Dec. 2004. Stopped Zoladex/Arimidex sept 2009 Still taking mistletoe shots (CAM therapy) Doing fine.
|